Thalidomide induces clinical remission and mucosal healing in adults with active Crohn's disease: a prospective open-label study

被引：0
|
作者：
Mao, R. [1 ]
He, Y. [1 ]
Ben-Horin, S. [2 ]
Chen, M. -H. [1 ]
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
[2] Sheba Med Ctr, Tel Aviv, Israel
来源：
JOURNAL OF CROHNS & COLITIS | 2017年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P441
引用
收藏
页码：S300 / S301
页数：2
相关论文
共 50 条
  • [41] Mucosal Healing in Crohn's Disease: Relevance for Clinical Outcomes
    Lowenberg, Mark
    D'Haens, Geert
    CURRENT DRUG TARGETS, 2012, 13 (10) : 1248 - 1251
  • [42] A prospective, open-label study of rituximab for remission induction in patients with refractory Wegener's granulomatosis
    Keogh, KA
    Fervenza, FC
    Ytterberg, SR
    Specks, U
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V187 - V187
  • [43] Enduring Clinical Remission in Refractory Celiac Disease Type II With Tofacitinib: An Open-Label Clinical Study
    Dieckman, Tessa
    Schumann, Michael
    Beaumont, Hanneke
    Bontkes, Hetty j.
    Koning, Frits
    Bouma, Gerd
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (11) : 2334 - 2336
  • [44] Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study
    Feagan, Brian G.
    Panes, Julian
    Ferrante, Marc
    Kaser, Arthur
    D'Haens, Geert R.
    Sandborn, William J.
    Louis, Edouard
    Neurath, Markus F.
    Franchimont, Denis
    Dewit, Olivier
    Seidler, Ursula
    Kim, Kyung-Jo
    Selinger, Christian
    Padula, Steven J.
    Herichova, Ivona
    Robinson, Anne M.
    Wallace, Kori
    Zhao, Jun
    Minocha, Mukul
    Othman, Ahmed A.
    Soaita, Adina
    Visvanathan, Sudha
    Hall, David B.
    Boecher, Wulf O.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (10) : 671 - 680
  • [45] Hyperbaric oxygen therapy for perianal Crohn's disease: An open-label pilot study
    Taylor, K.
    Heerasing, N.
    Cheung, W.
    Scarff, C.
    Mccann, C.
    Fock, A.
    Sparrow, M.
    Jakobovits, S.
    Ward, M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 94 - 94
  • [46] Extracorporcal photommatme therapy (Ecp) for refractory moderately active Crohn's disease (CD): A multicenter, open-label study
    Abreu, Maria T.
    Von tirpitz, Christian
    Mannon, Peter J.
    Sandborn, William J.
    Ochsenkuehn, Thomas
    Hanauer, Stephen B.
    Wang, Jim
    Reinisch, Walter
    Hardi, Robert
    Mayer, Lloyd F.
    Bisaccia, Emit
    Knobler, Robert
    Goerdt, Sergill
    Kaatz, Martin
    Williamson, Paul
    Van assche, Gert A.
    GASTROENTEROLOGY, 2007, 132 (04) : A157 - A157
  • [47] Maintenance therapy with infliximab for paediatric Crohn's disease: impact on clinical remission and mucosal healing in Polish paediatric patients with severe Crohn's disease
    Kierkus, Jaroslaw
    Dadalski, Maciej
    Szymanska, Sylwia
    Szymanska, Edyta
    Wegner, Agnieszka
    Gorczewska, Monika
    Oracz, Grzegorz
    Woynarowski, Marek
    Ryzko, Jozef
    PRZEGLAD GASTROENTEROLOGICZNY, 2012, 7 (01): : 26 - 30
  • [48] Adalimumab induction and maintenance therapy for Crohn's disease. An open-label study
    Lopez Palacios, N.
    Mendoza, J. L.
    Taxonera, C.
    Lana, R.
    Fuentes Ferrer, M.
    Diaz-Rubio, M.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2008, 100 (11) : 676 - 681
  • [49] Remission and clinical response to open label adalimumab over one year in patients with Crohn's disease
    Hanauer, SB
    Lukas, M
    Macintosh, DG
    Pollack, PF
    Kent, J
    GUT, 2006, 55 : A15 - A15
  • [50] Surrogate markers of mucosal healing in Crohn's disease patients in clinical remission under biological/immunomodulator treatment
    Siakavellas, S.
    Kostas, A.
    Kosmidis, C.
    Gizis, M.
    Papatheodoridis, G.
    Bamias, G.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S401 - S401
12345